Embryonic stem (ES) cells are a useful system to study cardiac differentiation in vitro. It has been difficult, however, to track the fates of chamber-specific cardiac lineages, since differentiation is induced within the embryoid body. We have established an in vitro culture system to track Nkx2.5(+) cell lineages during mouse ES cell differentiation by using green fluorescent protein (GFP) as a reporter. Nkx2.5/GFP(+) cardiomyocytes purified from embryoid bodies express sarcomeric tropomyosin and myosin heavy chain and heterogeneously express cardiac troponin I (cTnI), myosin light chain 2v (MLC2v) and atrial natriuretic peptide (ANP). After 4-week culture, GFP(+) cells exhibited electrophysiological characteristics specific to sinoatrial (SA) node, atrial, or ventricular type. Furthermore, we found that administration of 10 −7 M retinoic acid (RA) to embryoid bodies increased the percentage of MLC2v(-)ANP(+) cells; this also increased the expression of atrial-specific genes in the Nkx2.5/GFP(+) fraction, in a time-and dose-dependent fashion. These results suggest that Nkx2.5(+) lineage cells possess the potential to differentiate into various cardiomyocyte cell types and that RA can modify the differentiation potential of Nkx2.5(+) cardiomyocytes at an early stage.
stages, which makes it difficult to characterize the differentiation of cardiac lineages. Cardiomyogenic lineage can be assessed by isolating cardiac progenitors from EBs and allowing them to differentiate in vitro. The identification and isolation of intermediate stages in EB-derived cardiomyocyte differentiation is necessary to elucidate the mechanism of cardiac development.
Another difficulty in studying ES cell-derived cardiomyocytes is that EBs contain cell types with different chamber specificities (8, 12) . In in vivo cardiogenesis, diversification into chamber-specific cardiomyocytes is believed to occur at a very early stage in cardiac development (13) . Even before the formation of the heart tube, chamber-specific gene expression has already begun, and several genes are expressed along the anterior-posterior axis of the cardiac mesoderm. Ventricular cardiomyocytes differentiate from the anterior side of the cardiac mesoderm, while atrial cardiomyocytes differentiate from the posterior side. The chamber-specific differentiation occurs in EB-derived cardiomyocytes despite the absence of anterior-posterior positional information. Sinoatrial (SA) node-, atrium-, and ventricle-like cells have been identified at a later stage of development in ES cell-derived cardiomyocytes by electrophysiological methods (8, 9) . In mice, there are few immunological markers to identify chamber-specific cell lineages. Some markers, such as MLC2v, are specifically expressed in ventricular cardiomyocytes throughout development (14) . Most atrial-specific protein genes, which include myosin light chain 1a (Mlc1a), myosin light chain 2a (Mlc2a), α-myosin heavy chain (Mhca), and atrial natriuretic protein (Anp), are also expressed in ventricles at early stages of embryonic development (14, 15) . Nonetheless, it remains to be determined when chamber-specific diversification occurs in EBs.
Expression of transcription factor genes generally precedes that of structural genes. Several transcription factors are expressed in the heart primordium, where they play a pivotal role during heart development by controlling the expression of many cardiac muscle-specific genes (16) . Among these, Nkx2.5 is expressed throughout the course of development in the heart primordium, as well as in cardiomyocytes (17, 18) . It plays a critical role in the transcriptional regulation of cardiac-specific genes by acting in synergy with other transcription factors (19) (20) (21) (22) (23) (24) (25) . In mice, Nkx2.5 gene expression begins in the cardiogenic mesoderm at embryonic day 7.5, several hours before the α-cardiac actin (Actc1) and β-myosin heavy chain (Mhcb) genes begin to be activated (17) . Although it is also expressed in endoderm in the early stages of differentiation, Nkx2.5 is most strongly expressed in cardiomyocytes of the heart tube during cardiac development. In contrast to other transcription factors (such as Tbx5 and Irx4), which are non-uniformly expressed along the anterior-posterior axis of the linear heart tube, the Nkx2.5 gene has a rather ubiquitous expression pattern in the heart tube (14) . If Nkx2.5(+) cells include all cardiac precursor lineages during heart development, Nkx2.5 expression could be used to identify various types of cardiomyocyte precursors in a mixture of developing ES cells.
In this report, we have generated an ES cell line in which a GFP reporter gene has been knocked into one of the Nkx2.5 loci. We could obtain pure Nkx2.5/GFP(+) cells from d8 EBs, after the beginning of spontaneous contraction. We demonstrate that the Nkx2.5(+) cells derived from ES cells represent cardiac precursor cells and that they indeed diversify into SA node-, atrial-, or ventricular-like cardiomyocytes. These ES cell-derived cardiomyocytes exhibit immunologically different characteristics shortly after purification, suggesting that they are in various stages of differentiation and that they have already established chamber specificity at this early stage in EB development. Finally, we report the effects of retinoic acid (RA) on the chamber-specific differentiation of ES cells. Treatment with RA increases the percentage of MLC2v(-)ANP(+) cells and induces atrial-specific gene expression in the Nkx2.5(+) cell fraction.
MATERIALS AND METHODS

Vector construction and homologous recombination
Murine Nkx2.5 genomic clones were isolated from a lambda FIXII strain 129/Sv genomic library (Stratagene, La Jolla, CA) by using mouse Nkx2.5 cDNA probes (18) . An 11-kb fragment extending from the Not I site to the Kpn I site was cloned into pBlueScriptII SK+ (Stratagene), and an Nco I site was introduced at the initiation codon by site-directed PCR mutagenesis (Fig. 1A) . A part of the coding sequence for the Nkx2.5 gene (from the Nco I site to the Sma I site) was excised and replaced with a promoter-less EGFP gene (Clontech Laboratories Inc., Palo Alto, CA) and a puromycin resistance gene driven by the Pgk1 gene promoter (26) . The gene encoding the diphtheria toxin A fragment (27) was cloned into the Kpn I site for negative selection. Among puromycin-resistant ES cell colonies, the homologous recombination event was confirmed by RT-PCR and by Southern blotting using an external probe as shown in Fig. 1B .
Culture and differentiation of ES cells
The 129/Ola-derived ES cell lines used here are ht7 (provided by Hitoshi Niwa, University of Osaka, Japan) and its derivatives. These cell lines carry the hygromycin resistance gene in one of the Oct-3/4 loci, which allows for selection of Oct-3/4-positive undifferentiated stem cells (28) . The cells were grown routinely on gelatinized dishes without feeder cells by using culture medium containing Glasgow-modified Eagle's medium (GMEM, Sigma-Aldrich, St. Louis, MO), 1000 units/ml leukemia inhibitory factor (ESGRO™, Chemicon International Inc., Temecula, CA), 100 µg/ml hygromycin (Invitrogen Corp., Carlsbad, CA), 10% heat-inactivated fetal calf serum (FCS; Equitech-Bio Inc., Kerrville, TX), 1× non-essential amino acids (Invitrogen), 1 mM sodium pyruvate, 0.1 g/ml penicillin, 0.1 mg/ml streptomycin, and 0.1 mM 2-mercaptoethanol. Differentiation of ES cells was induced through formation of EBs as described previously (29) . Briefly, EBs were generated by plating an ES cell suspension at a final concentration of 2.5 × 10 4 cells/ml in 20 µl (500 cells) of a differentiation medium (GMEM containing 10% FCS, 0.1 mg/ml penicillin, 0.1 mg/ml streptomycin, and 0.1 mM 2-mercaptoethanol) on the lid of bacterial dishes. After incubation in hanging drops for 2 days, 60 EBs were transferred into bacterial Petri dishes together with 10 ml of differentiation medium and cultured as floating EBs for N days (designated as dN) until dissociation for FACS analysis. We mainly used floating EBs or cells sorted from floating EBs for most of the analysis. For the experiments shown in Fig. 1C and Fig. 2A , EBs were transferred onto gelatin-coated dishes at d5 or d6 and were cultured further for N days (designated as d5+N or d6+N, respectively) to observe spontaneous contraction.
Sorting and culture of GFP(+) cells
Embryoid bodies were dissociated with trypsin-EDTA (0.25% trypsin, 1 mM EDTA, Invitrogen) for 3 min at 37°C and light pipetting before the addition of differentiation medium to neutralize the trypsin. Cells were then resuspended into a smaller volume of medium and were pipetted to obtain single-cell suspensions. For detection of GFP, the single cells were resuspended in Hank's balanced salt solution containing 1% bovine serum albumin, and 2.5 µg/ml propidium iodide (PtdIns), and analyzed with FACSCalibur™ or FACSVantage™ SE (BD Biosciences, San Jose, CA). The sort gate for GFP(+) cells was established on the basis of the forward-scattered light (FSC), side-scattered light (SSC), and PtdIns and GFP fluorescence intensities of the control ES cells. Cells were sorted into culture medium and were re-analyzed to estimate sort purity. Typically, ~1-2 × 10 4 GFP(+) cells were obtained from 1 × 10 7 cells derived from d8 EBs. The GFP(+) cells were sorted from d8 or d10 EBs and further cultured on gelatin/laminin-coated dish for N days (designated as d8+N or d10+N, respectively).
Gene expression analysis by real-time RT-PCR
Total RNA was isolated from EBs by using TRIzol® Reagent (Invitrogen). RNA samples were treated with DNaseI (Promega Corp., Madison, WI) to eliminate genomic DNA contamination, and cDNA was synthesized by using SuperScript™ II reverse transcriptase (Invitrogen). For real-time PCR, the reaction was performed with a QuantiTect™ SYBR® Green PCR kit (QIAGEN, Valencia, CA) and the products were analyzed with an ABI PRISM® 7700 Sequence Detection System (Applied Biosystems, Foster City, CA). Levels of Gapdh transcript were determined by using TaqMan® Rodent GAPDH Control Reagents (Applied Biosystems) to normalize cDNA levels. The gene-specific primers used are indicated in Table 1 .
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde-PBS for 10 min at 4°C. They were washed three times with PBS and treated with a blocking buffer (0.1% Triton X-100, 2% skim milk in PBS) at room temperature for 1 h. After incubation with a primary antibody, cells were washed three times with the blocking buffer and incubated with a secondary antibody. The mouse monoclonal antibodies used are as follows: anti-myosin heavy chain antibody (MHC) F36.5B9 (Alexis Corp., San Diego, CA), anti-tropomyosin antibody CH1 (Sigma), anti-MLC2v antibody F109.3E1 (Alexis Corp.), and anti-cTnI antibody TI-1 (DSMZ, Braunschweig, Germany). Both anti-MHC and anti-tropomyosin antibodies recognize embryonic cardiomyocytes and skeletal myocytes, as well as neonatal atrial and ventricular cardiomyocytes. The rabbit polyclonal antibodies are as follows: anti-ANP (Protos Biotech Corp., New York, NY) and anti-chloramphenicol acetyltransferase (CAT) antibody (Sigma). The secondary antibodies used for immunofluorescence were Alexa546-or Alexa488-conjugated anti-mouse or anti-rabbit IgG (Molecular Probes Inc., Eugene, OR). Cells were observed in an Olympus IX70 or an Olympus BX51 microscope, and the image data were acquired with a SPOT CCD camera (Diagnostic Instruments Inc., Sterling Heights, MI) or a Fluoview (Olympus Optical Co., LTD., Tokyo, Japan).
Electrophysiological studies
To examine the electrophysiological and pharmacological properties of cardiac cells derived from ES cells, we recorded action potentials by using a patch-clamp technique in the whole cell configuration at 37°C. Cells were cultured on gelatin-coated cover slips for 28 days after sorting with GMEM-supplemented 10% FBS. The cover slips containing cells were perfused with the normal Tyrode's solution composed of 143 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl 2 , 0.25 mM MgCl 2 , 0.25 mM NaH 2 PO 4 , 5 mM glucose, and 5 mM HEPES-NaOH, pH 7.4. The pipette solution contained 80 mM KCl, 60 mM KOH, 40 mM aspartate, 10 mM EGTA, 5 mM MgATP, 5 mM sodium creatine phosphate, 0.65 mM CaCl 2 , and 5 mM HEPES-KOH (pH 7.3). Action potentials were elicited by applying a stimulus current at 1.0 Hz with a pulse-width of 1 ms. To examine the sensitivity to muscarinic stimulation, carbamyl choline (Sigma) was applied to quiescent cells. Data were sampled by a computer through a digitizer at 10 kHz (Digidata 1200, Axon Instruments, Burlingame, CA) and were analyzed by using pClamp software (Clampex and Clampfit, Axon Instruments).
RESULTS
Generation and characterization of the Nkx2.5GFP ES cell line
A targeting vector was constructed ( Fig. 1A ) in which a part of the first coding exon (from the initiation codon to the Sma I site) in the Nkx2.5 gene was replaced with the EGFP coding sequence together with the Pgk1 promoter-driven puromycin resistance gene. GFP fluorescence was observed in the beating areas of EBs derived from these clones but not in those of controls (Fig.  1C) . As all ES clones tested (n=6) exhibited virtually the same level of GFP fluorescence, we used a single ES clone (designated "Nkx2.5GFP ES" in this report) for several experiments. The Nkx2.5GFP ES cell clone differentiated into beating EBs as frequently as the control ES cells ( Fig.  2A) 
Purification of Nkx2.5/GFP(+) cells from EBs
To further characterize Nkx2.5/GFP(+) cells, we purified GFP(+) cells from d8 EBs and analyzed them by immunostaining. The purity of the sorted GFP(+) cells was typically ~97% (Fig. 3A) . The GFP(+) fraction was analyzed by immunostaining with anti-MHC or anti-tropomyosin antibody. As shown in Table 2 , >98% of GFP(+) cells were stained positively for MHC and tropomyosin, compared with <1% of GFP(-) cells. We next isolated the GFP(+) fraction of d7 EBs and analyzed it by real-time RT-PCR. As shown in Fig. 3B , the GFP(+) fraction preferentially expressed genes for transcription factors active in the cardiac cell lineage, including Gata4, Mef2C, and Tbx5, at significantly higher levels than the GFP(-) fraction. The GFP(+) fraction also expressed genes encoding contractile proteins, including Actc1, Mhcb, Mhca, Mlc2a, and Mlc2v. We also detected Mink, which is known to be expressed in the cardiac conduction system (31), in the GFP(+) fraction. In contrast, Gata1 and Cdh5, which are expressed in the hematopoietic and endothelial lineages, respectively (32), were detected preferentially in the GFP(-) fraction. We detected neither myogenin nor MyoD transcript (33) by real-time RT-PCR (cycle number=40) in floating EBs at any examined time points (d3-d10) (data not shown). These results indicate that almost all Nkx2.5/GFP(+) cells represent developing cardiomyocytes, but not skeletal myocytes, and that this purification procedure is highly successful in enriching for EB-derived cardiomyocytes.
In vitro differentiation of purified Nkx2.5/GFP(+) cells
To follow the differentiation of Nkx2.5/GFP(+) cells, we sorted them at d8 from floating EBs and cultured them on a gelatin/laminin-coated dish for N days (designated as d8+N) in standard culture medium containing 10% fetal calf serum (FCS). While in culture, Nkx2.5/GFP(+) cells grew larger and migrated toward each other and appeared to grow slightly in cell number (Fig. 4A) . After a few days, the Nkx2.5/GFP(+) cells formed colonies, which contracted synchronously and exhibited highly organized myofibrils (Fig. 4B) . To examine the differentiation state of these cardiomyocytes, we stained them for cardiac troponin I (cTnI), a marker of late-stage cardiomyocytes in EBs (11). Some Nkx2.5/GFP(+) cells sorted from d8 EBs weakly expressed cTnI at d8+1 (36±11%). The population of cTnI(+) cells increased over time (42±7% at d8+2, 69±5% at d8+4), and the majority of GFP(+) cells strongly expressed cTnI at d8+8 (89±6%). These results suggest that Nkx2.5/GFP(+) cells harvested from d8 EB contain cardiomyocytes in different stages of differentiation, but that almost all of them can differentiate into cTnI-expressing cells in culture.
Electrophysiological characterization of Nkx2.5/GFP(+) cells
To characterize the electrophysiological properties of Nkx2.5/GFP(+)cells, we examined action potential configurations under patch clamp. We found that 17 out of 20 cells (85%) showed continuous spontaneous beating at d10+7. At d10+28, 2 out of 15 cells (13%) showed spontaneous beating. Figure 5 shows representative tracing of action potentials of Nkx2.5/GFP(+) cells at d10+28. Two spontaneous beating cells demonstrated prominent pacemaker depolarization and slow upstroke phase, as characteristic of SA node cells. Thirteen cells were quiescent with resting membrane potential at -71 ± 2.5 mV, and action potential duration at 90% repolarization (APD 90 ) of 38.5 ± 9.5 ms. To further examine the chamber-specific characteristics of the quiescent cells, the effect of carbamyl choline (CCh, 10 µM), a muscarinic agonist, was tested. In 6 out of 13 quiescent cells (Fig. 5B) , the resting membrane potential was hyperpolarized by 14±2.5 mV in response to CCh. In the remaining 7 cells, the action potential configuration was not affected (Fig. 5C ). Carbamyl choline application to the spontaneously beating cells resulted in an appreciable hyperpolarization and a slowing of the beating rate. The CCh-sensitive and the CCh-insensitive quiescent cells were referred to atrial-type and ventricular-type, respectively. The proportion of atrial-type cells (40%) and that of ventricular-type cells (46%) were comparable (Fig. 5D ). Nkx2.5/GFP(+) cells at earlier stages (d10+14, d10+21) also showed spontaneous beating (SA node-type) and quiescent (atrial-type or ventricular-type) action potentials (data not shown). These results indicate that Nkx2.5/GFP(+) cells have the potential to differentiate into various types of cardiac cells including SA node-type, atrial-type and ventricular-type cells.
Heterogeneity of purified Nkx2.5/GFP(+) cells at early stages
In chick, cardiomyocyte diversification has been identified by the expression of molecules specific to atrial or ventricular cell lineages (13) , before the establishment of distinct heart chambers. To see whether early-stage EBs contain distinct precursor cell types, we examined the immunoreactivity of purified and cultured Nkx2.5/GFP(+) cells by using anti-MLC2v antibodies (Fig. 6, Fig. 7A ) and found that ~20-30% of Nkx2.5/GFP(+) cells were MLC2v(+) at d8+4 (Fig.  7B ).
In mice, there are no known atrial lineage-specific contractile proteins. It is possible that the MLC2v(-) cells represent undifferentiated ventricular cardiomyocytes. To further characterize these cells, we transfected them with a quail slow myosin heavy chain 3 (SMyHC3) promoter linked to a CAT reporter (34) . The quail SMyHC3 gene is expressed in the sinoatrial region of heart throughout development, which makes it a good marker for presumptive atrial cells (35) . We confirmed that this promoter is atrial-specific in cultured mouse cardiomyocytes by examining atrial or ventricular primary cardiomyocytes (Fig. 6d-i) . Using the same detection conditions, we detected the CAT protein in some MLC2v(-) cells in the Nkx2.5/GFP(+) fraction (Fig. 6c) . Thus, the Nkx2.5/GFP(+) cell fraction contains both atrial-and ventricular-type cardiac precursors, and that they already show immunologically distinct characteristics shortly after sorting.
Effect of retinoic acid on cardiogenesis of EBs
Retinoic acid has been shown to affect cardiac diversification in EBs and embryos in a dose-and time-dependent manner (36) . To examine the effect of RA, we treated EBs with RA or disulfiram, which is an inhibitor of retinaldehyde dehydrogenase (35) The transcription factor genes Hrt1 and Coup-tfII are preferentially expressed in the anterior part of the heart tube during the early stages of heart development (37, 38) . As shown in Fig. 7C , expression of both Hrt1 and Coup-tfII was strongly induced by treatment of EBs with 10 −7 M RA.
Similarly, the levels of other atrial genes (although they are not exclusive to atrial cardiomyocytes), Mhca and Mlc2a, were higher in the GFP(+) cell fraction of 10 −7 M RA-treated EBs. On the other hand, disulfiram (10 −5 or 10 −6 M) did not significantly affect the expression level of these genes in the Nkx2.5/GFP(+) fraction. Taken as a whole, these data suggest that exogenous 10 −7 M RA preferentially induces atrial cardiomyocyte differentiation in EBs, but that blocking of endogenous RA production does not prominently affect the direction of diversification in our culture system. (24) . These results suggest that Nkx2.5 strictly regulates expression levels of these target genes but that a half dose of Nkx2.5 is sufficient to induce cardiac differentiation in vitro.
DISCUSSION
Identification and purification of EB-derived cardiomyocytes
Because Nkx2.5 is also expressed in such non-cardiac tissues as the pharynx and stomach (43) , it is possible that the GFP(+) cell population includes non-cardiac cells. We demonstrated that almost all GFP(+) cells purified from EBs stained with both anti-MHC and anti-tropomyosin antibodies, indicating that most GFP(+) cells we collected are developing cardiomyocytes. Reliable separation and collection of GFP(+) cells, however, was possible only when the GFP signal was sufficiently high (d7 or later), whereas the endogenous Nkx2.5 gene could already be detected from d5. It will be necessary to further improve our method for marking Nkx2.5(+) cells in order to characterize them at earlier stages. Introducing extra copies of Nkx2.5 enhancer-driven EGFP would help us to detect earlier stages of cardiomyocyte development.
Differentiation and diversification of purified Nkx2.5/GFP(+) cells
Cardiac TnI is a subunit of the thin filament-associated troponin-tropomyosin complex and plays a pivotal role in regulating cardiac muscle contraction (44) . Isoform switching of troponin I is controlled developmentally during vertebrate heart development (45). In EBs, cardiac TnI is expressed only in a small proportion of beating foci at early stages of cardiac differentiation (foci contracting for less than 5 days), while it is expressed in most beating foci at later stages (contracting for more than 20 days) (11) . Consistent with the report by Westfall et al, we observed that some Nkx2.5/GFP(+) cells weakly expressed cTnI just after plating, but many of them strongly expressed it after several days in culture. This suggests that Nkx2.5/GFP(+) cells can differentiate into cTnI(+) cells after isolation from EBs.
In the present study, most of Nkx2.5/GFP(+) cells at an early stage of culture (d10+7) were spontaneously beating as reported by Maltsev et al (7) . The Nkx2.5/GFP(+) cells at an later stage (d10+28) showed variable action potential characteristics including SA node-type, atrial-type and ventricular-type. This means that the Nkx2.5/GFP(+) cell lineage may be pluripotent in differentiation, not only for working myocytes, but also for myocytes of the specialized conduction system. Compared with the cell sorting method using a ventricular specific marker, MLC2v, as reported by Muller et al (41) and Meyer et al. (42) , our method using Nkx2.5 as a marker may be more useful for cell transplantation therapy in the heart with pacemaking dysfunction.
Signs of diversification are already apparent shortly after sorting; immunologically diverse cell types were stained differentially with MLC2v and ANP antibodies. Moreover, an atrial-specific promoter was active in some MLC2v(-) cells. These results suggest that the Nkx2.5/GFP(+) cell fraction contains both atrial-and ventricular-type cardiac precursors and that they already show immunologically distinct characteristics at early stages of EB development when their electrophysiological properties are not evident.
Retinoic acid modifies the diversification of cardiomyogenic cell lineages within EBs
Chamber-specific cardiomyocyte differentiation is closely related to positional information along the embryonic anterior-posterior axis. In the absence of a positional cue, other signals must regulate chamber-specific differentiation in EBs. Retinoic acid is a candidate regulator of chamber-specific differentiation along the anterior-posterior axis. In chick or mouse embryo, excess administration of RA results in posteriorization of the heart tube (characterized by an enlarged atrium and reduced ventricle), whereas a lack of RA signaling results in its anteriorization (characterized by a smaller atrium and a large ventricle) (35, (46) (47) (48) (49) . We observed that administration of 10 −7 M RA to EBs increased the percentage of MLC2v(-)ANP(+) cells, while inducing expression of atrial-specific genes as well. Thus, the effect of exogenous 10 −7 M RA on EBs seems to be similar to that on chick or mouse embryos. Disulfiram, an inhibitor of retinaldehyde dehydrogenase, however, did not increase the percentage of MLC2v(+) prominently, nor decrease the expression of atrial genes. These results suggest that endogenous RA production may not be important in determining diversification in our culture system. Alternatively, endogenous or a low level of RA may be required for the development of both atrial and ventricular cardiomyocyte lineages. We observed that 10 −5 M disulfiram reduced the level of both atrial and ventricular genes in the Nkx2.5/GFP(+) cell fraction. Wobus et al also reported that RA at 10 −8 M (d5-d15) promoted ventricular myocyte differentiation (36) .
In summary, we have established an in vitro system to track the fate of Nkx2.5(+) cardiomyocytes derived from ES cells. They indeed differentiate and diversify into various types of cardiomyocytes, and exogenous RA can modify this behavior. These properties seem to be closely related to those of cardiomyocytes differentiated in vivo. Thus, this system is predicted to be useful to further understanding of the mechanism of cardiomyocyte differentiation and diversification at a cellular level and will provide us useful information to manipulate and control in vitro cardiac differentiation from multi-potent stem cells. Embryoid bodies were dissociated on day 8. Cells in the unsorted and sorted fractions were plated on gelatin-coated dishes and stained with anti-MHC or anti-tropomyosin after overnight culture. More than 300 cells were counted. Values are given as mean ± SE from three independent experiments. The 3′ probe shown was used for Southern blot analysis. E, EcoRI; K, KpnI; N, NotI; Nc, NcoI, S, SalI; Sm, SmaI. B) Genotyping of ES cell clones. Genomic DNA was digested with EcoRI and analyzed by Southern blotting. Hybridization with a 3′ probe revealed the expected 8 kb and 3 kb fragments from the wild-type and targeted alleles, respectively. C) Spontaneous beating area of differentiated EBs. Embryoid bodies derived from a control ES cell line and an Nkx2.5GFP ES cell line were transferred onto gelatin-coated plates at d6 and cultured for an additional 2 days (d6+2). Spontaneously beating areas (inside of dotted line) had discernible fluorescence in the Nkx2.5GFP EBs (lower) but not the control EBs (upper). Bars, 100 µm. Table 1 . Total levels of mRNA were normalized with Gapdh, and relative quantities of each genespecific mRNA were determined as ratios to those of d8 control EBs. Values are given as mean ± SE from four independent experiments. 
